OverviewSuggest Edit

Synspira Therapeutics is a company providing treatment for people with cystic fibrosis and other rare diseases such as primary ciliary dyskinesia and bronchiectasis. It develops SNSP113, an inhaled non-absorbed glycopolymer therapeutics.
HQFramingham, MA, US

Latest Updates

Employees (est.) (Sept 2021)18(-5%)
Cybersecurity ratingBMore

Synspira Office Locations

Synspira has an office in Framingham
Framingham, MA, US (HQ)
10 Speen St
Show all (1)

Synspira Financials and Metrics

Summary Metrics

Founding Date


Synspira total Funding

$11.2 m

Synspira latest funding size

$3 m

Time since last funding

4 years ago

Synspira investors

Synspira's latest funding round in January 2018 was reported to be $3 m. In total, Synspira has raised $11.2 m
Show all financial metrics

Synspira Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Synspira Online and Social Media Presence

Embed Graph

Synspira News and Updates

Synspira Therapeutics Announces Expanded Agreement with Cystic Fibrosis Foundation to Advance Promising Treatments for Cystic Fibrosis

FRAMINGHAM, Mass., Oct. 20, 2020 /PRNewswire/ -- Synspira Therapeutics, a clinical-stage biopharmaceutical company dedicated to improving the lives of people with cystic fibrosis (CF) and other rare diseases, announced today that the Cystic Fibrosis Foundation has made equity and...

Synspira Frequently Asked Questions

  • When was Synspira founded?

    Synspira was founded in 2017.

  • How many employees does Synspira have?

    Synspira has 18 employees.

  • Who are Synspira competitors?

    Competitors of Synspira include ReCode Therapeutics, Praxis Precision Medicines and Cardior Pharmaceuticals.

  • Where is Synspira headquarters?

    Synspira headquarters is located at 10 Speen St, Framingham.

  • Where are Synspira offices?

    Synspira has an office in Framingham.

  • How many offices does Synspira have?

    Synspira has 1 office.